Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:category |
Antithrombotic agent
Cardiovascular drug |
| gptkbp:contraindication |
Severe liver disease
Hypersensitivity Active bleeding |
| gptkbp:discoveredIn |
20th century
|
| gptkbp:example |
gptkb:Aspirin
gptkb:Clopidogrel gptkb:Ticagrelor Dipyridamole Abciximab Eptifibatide Prasugrel Tirofiban |
| gptkbp:indication |
gptkb:Coronary_artery_disease
gptkb:Peripheral_artery_disease Atrial fibrillation (in some cases) |
| gptkbp:mechanismOfAction |
Inhibits platelet aggregation
|
| gptkbp:regulates |
Platelet function
|
| gptkbp:relatedTo |
Anticoagulant
Thrombolytic agent |
| gptkbp:routeOfAdministration |
gptkb:Oral
Intravenous |
| gptkbp:sideEffect |
Bleeding
Gastrointestinal upset |
| gptkbp:usedFor |
Prevention of blood clots
Prevention of myocardial infarction Prevention of stroke |
| gptkbp:bfsParent |
gptkb:CHEMBL573
gptkb:CHEMBL960 gptkb:CHEMBL92 |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Antiplatelet agent
|